Rejected for a Positive Cannabis Test in New Jersey? Now Applicants Can Sue.

Key Takeaways

• NJ appellate court grants private right to sue under CREAMMA
• Employers cannot rely on costly retests as a safe harbor
• Federal‑court split means outcomes depend on chosen forum
• Safety‑sensitive roles and federal contracts remain exempt
• Companies must update drug policies to reflect 2021 legalization

Pulse Analysis

New Jersey’s Cannabis Regulatory, Enforcement Assistance, and Market Modernization Act (CREAMMA) was designed to protect workers from discrimination based on legal recreational cannabis use. While the statute barred employers from refusing hires solely because of a positive test, the 2024 Third Circuit decision left applicants without a practical remedy, as the Cannabis Regulatory Commission’s enforcement reach excludes most private employers. The May 2026 Appellate Division opinion resolves that gap by recognizing a private right of action, effectively turning CREAMMA’s protections into enforceable court‑room rights. This shift aligns state law with its policy intent and signals that statutory language, even without explicit enforcement mechanisms, can generate judicially created remedies.

For New Jersey businesses, the ruling is a wake‑up call to audit pre‑employment screening practices. Employers must identify whether they fall under the narrow exemptions for federal contractors, grant recipients, or safety‑sensitive positions; otherwise, rescinding offers after a positive cannabis test now exposes them to statutory claims, breach‑of‑contract suits, and privacy allegations. The court’s rejection of a “re‑test at applicant’s expense” strategy underscores that merely offering a second test does not shield firms from liability. Companies should revise drug‑testing policies, communicate clear timelines, and consider eliminating cannabis testing altogether for non‑safety roles to mitigate risk.

The split between New Jersey state courts and the federal Third Circuit creates a forum‑selection dilemma for future litigants. Plaintiffs filing in state court can now survive CREAMMA claims, while those in federal court may still face dismissal. This divergence may encourage more applicants to pursue state‑court filings, prompting employers to anticipate parallel litigation tracks. Moreover, the decision could influence other states with similar cannabis‑employment statutes, prompting courts to grapple with the enforceability of protective provisions. As the industry matures, legal clarity around cannabis‑related hiring will become a competitive advantage for firms that proactively align policies with evolving jurisprudence.